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Endometriosis is a common gynecologic condition affecting 6–10%
of females and up to 50% of women with pelvic pain and/or infertility
[1]. Signs and symptoms of endometriosis include dysmenorrhea,
dyspareunia, dysuria, dyschezia, menorrhagia, and infertility. Common
clinicalﬁndings include endometriomas, pelvic and peritoneal implants,
and pelvic adhesions. Endometriosis is most often diagnosed by the
presence of pelvic pain in relation to menstruation, although deﬁnitive
diagnosis is made by laparoscopic identiﬁcation of implants and patho-
logic sampling. Endometriosis may mimic other conditions, including
ovarian neoplasms, ectopic pregnancy, pelvic inﬂammatory disease, in-
terstitial cystitis, adenomyosis, iatrogenic pelvic adhesions, irritable
bowel syndrome, colon cancer, or diverticulosis [1]. Treatment is
based on severity of symptoms and the patient's reproductive plans.
Treatment options include pain management, hormonal suppression,
or deﬁnitive surgical management.
Pseudomyxoma peritonei (PMP) is a rare condition characterized by
mucinous ascites andmucinous epitheliumwithin the peritoneal cavity,
most commonly associated with gastrointestinal or primary peritoneal
carcinomas of the appendix [2]. PMP is suspected if computerized to-
mography (CT) shows peripheral ﬂuid collections with centralization
of abdominal organs and scalloping of abdominal organs, as well as
the presence of increased abdominal girth andmalnutrition. Laboratory
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followed by hyperthermic intraperitoneal chemotherapy (HIPEC). We
present a case of a young women with endometriosis whose clinical
presentation was consistent with PMP.
2. Case Report
A 25 year-old nulliparous female presented to her primary care physi-
cian with threemonths of diffuse abdominal pain and a 30-pound weight
gain. Hermedical historywas signiﬁcant formigraines, depression, and id-
iopathic hemolytic anemia requiring transfusion in 2011. Family history
was signiﬁcant for a brotherwith leukemia. She had normalmenstrual cy-
cles, no dyspareunia or dysmenorrhea, and no change in bowel habits. She
did later endorseoccasional abdominal pain andbrief,monthly episodes of
epistaxis. On exam, her abdomen was protuberant with a positive ﬂuid
wave. Pelvic exam was limited by ascites but revealed a mobile, non-ten-
der cervix without nodularity, a normal-sized, anteverted uterus, and no
palpable pelvic masses. A urine pregnancy test was negative. CT scan re-
vealedmulti-loculated,multi-septated, lowattenuationﬂuidﬁlling the ab-
domen and pelvis and a 4.5 × 6.7 × 6 cm left adnexal mass (Fig. 1). The
patient was referred to a gynecologic oncologist for further management.
Further studies included a complete blood count and chemistries,
which were normal. CA-125 was elevated at 223. Imaging was
concerning for pseudomyxoma peritonei given ﬁndings of the multi-
septated ﬂuid collections and bowel centralization.
3. Procedure
The patient was referred to gynecologic oncology for surgical inter-
vention. An exploratory laparotomy was recommended for pelvic
mass resection, ﬂuid drainage, and possible hysterectomy, bilateral
salingoophorectomy, bowel resection, appendectomy, and intraopera-
tive hyperthermic intraperitoneal chemotherapy. Fertility preservation
was desired.
She underwent an exploratory laparotomy, removal of loculated as-
cites, removal of peritoneal endometriotic implants, and ovarian preser-
vation. Intraoperative ﬁndings were signiﬁcant for large, cystic masses
ﬁlling the abdominal cavity. However, these appeared to arise from
the peritoneum rather than ovary or bowel and had no deﬁnitive
blood supply. Additionally, adhesions and endometriomas were notede CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. CT images at presentation demonstrating multi-sepatated, low attenuation ﬂuid with centralization of the bowel.
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sected from the peritoneum. Ovaries and uterus were without masses
and were preserved. Appendectomy and omentectomy were per-
formed, but bowel resection and chemotherapy were not indicated
given the intraoperative ﬁndings.
Final pathology revealed a 30 cm mucicarmine and calretinin nega-
tive, WT-1+/CD10+/PR+ serous cystadenoma with endometriosis.
The patient had an uncomplicated postoperative course and was
discharged home on postoperative day three with a prescription for
an oral contraceptive (Fig. 2).
4. Discussion
Thenovelty of this case lies in the common features anddramaticdiffer-
ences in management between pseudomyxoma peritonei, an uncommon
ﬁnding that portends malignancy, and endometriosis, which affects N175
million women worldwide [3]. Moreover, the ﬁnding of a serous
cystadenoma is thought to have arisen from preexisting endometriosis.
While endometriosis more commonly presents as isolated, superﬁ-
cial implants b5 cm in aggregate, a review of the literature has
identiﬁed four case reports of endometriosis presenting as large, cystic
endometriomas [4,5,6,7]. Endometriosis presenting alongside frank as-
cites is evident in the literature as well; however, this is more common-
ly confused with Meigs syndrome than pseudomyxoma peritonei [8,9].
An increasing body of evidence that endometriosis is associated with a
chronic inﬂammatory state, increased cyclooxygenase-2 activity, ele-
vated activated macrophages, and proinﬂammatory cytokines suggestsFig. 2. Histologic images from cystic tissue featuring endometrioid gland with cilia and characthat ﬂuid extravasation and edema is an expected albeit atypical ﬁnding
in endometriosis [3,10]. This case highlights that endometriosis should
be part of any differential diagnosis for premenopausal patients pre-
senting with a complex pelvic ﬂuid collection.
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